Technical Analysis for NPCE - Neuropace, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Calm After Storm | Range Contraction | 0.11% | |
| Upper Bollinger Band Walk | Strength | 0.11% | |
| Wide Bands | Range Expansion | 0.11% | |
| Calm After Storm | Range Contraction | 2.68% | |
| Upper Bollinger Band Walk | Strength | 2.68% | |
| Inside Day | Range Contraction | 2.68% | |
| Wide Bands | Range Expansion | 2.68% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | 2 days ago |
| Up 3% | 2 days ago |
| Up 2% | 2 days ago |
| Up 1% | 2 days ago |
| Down 5% | 2 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Neuroscience Epilepsy Neuromodulation Neurophysiology Neurotechnology Electroencephalography Seizure Neuroprosthetics
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Neuroscience Epilepsy Neuromodulation Neurophysiology Neurotechnology Electroencephalography Seizure Neuroprosthetics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.15 |
| 52 Week Low | 5.45 |
| Average Volume | 78,599 |
| 200-Day Moving Average | 9.50 |
| 50-Day Moving Average | 7.05 |
| 20-Day Moving Average | 7.54 |
| 10-Day Moving Average | 8.46 |
| Average True Range | 0.79 |
| RSI (14) | 67.43 |
| ADX | 23.54 |
| +DI | 30.04 |
| -DI | 18.17 |
| Chandelier Exit (Long, 3 ATRs) | 8.04 |
| Chandelier Exit (Short, 3 ATRs) | 7.83 |
| Upper Bollinger Bands | 9.90 |
| Lower Bollinger Band | 5.18 |
| Percent B (%b) | 0.85 |
| BandWidth | 62.64 |
| MACD Line | 0.68 |
| MACD Signal Line | 0.46 |
| MACD Histogram | 0.225 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.24 | ||||
| Resistance 3 (R3) | 10.17 | 9.75 | 10.07 | ||
| Resistance 2 (R2) | 9.75 | 9.48 | 9.79 | 10.01 | |
| Resistance 1 (R1) | 9.47 | 9.32 | 9.26 | 9.54 | 9.95 |
| Pivot Point | 9.05 | 9.05 | 8.95 | 9.09 | 9.05 |
| Support 1 (S1) | 8.77 | 8.78 | 8.56 | 8.84 | 8.43 |
| Support 2 (S2) | 8.35 | 8.62 | 8.38 | 8.37 | |
| Support 3 (S3) | 8.07 | 8.35 | 8.31 | ||
| Support 4 (S4) | 8.14 |
